RBC Capital Lifts PT on Nuvation Bio (NUVB) to $13 From $12 – Here's Why [Yahoo! Finance]
Nuvation Bio Inc. Class A (NUVB)
Company Research
Source: Yahoo! Finance
Nuvation Bio Inc. (NYSE: NUVB ) is one of the best penny stocks to buy according to Reddit . On March 3, RBC Capital cut the price target on Nuvation Bio Inc. (NYSE:NUVB) to $13 from $12 while maintaining an Outperform rating on the shares. The rating update came after the company reported its fiscal Q4 results, with the firm telling investors in a research note that the launch of Ibtrozi is continually showing promise. Physicians are using increasing amounts of the drug in their ROS1 patients, driven by good tolerability and high efficacy. It added that with an opportunity of over $650 million and even greater long-term upside potential on safu, shares are undervaluing the two pillars of the company. Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? Nuvation Bio Inc. (NYSE:NUVB) released its fiscal Q4 and full-year 2025 results on March 2, reporting that it successfully started 216 patients on IBTROZI ® (taletrectinib) in fiscal
Show less
Read more
Impact Snapshot
Event Time:
NUVB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NUVB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NUVB alerts
High impacting Nuvation Bio Inc. Class A news events
Weekly update
A roundup of the hottest topics
NUVB
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVBGlobeNewswire
- NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law FirmBusiness Wire
- Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Swings [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVBPR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVBGlobeNewswire
NUVB
Earnings
- 3/2/26 - In-Line
NUVB
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- NUVB's page on the SEC website